Foresight and Bumhan, a Leading South Korean Bus Manufacturer, to Develop Autonomous Electric Bus Solution
Initially the parties will collaborate to develop and bring to market advanced…
Genius Group acquires Bitcoin Learning Platform, XD Academy
SINGAPORE, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American:…
Gaxos Labs Unveils Visual Editor for Godot Gaming Engine
December 06, 2024 07:30 ET | Source: GAXOS.AI INC. Roseland, NJ, Dec.…
BitFuFu Announces November 2024 Production and Mining Operations Update
December 06, 2024 06:00 ET | Source: BitFuFu Inc. ● 1,643 BTC…
Dynamite Blockchain Announces Strategic Rebranding and Provides Corporate Updates
The Company Announces New Website, Name, Logo and Ticker Symbol "KAS" to…
Press Release: Availability of the revised financial statements for Sanofi excluding Opella
Availability of the revised financial statements for Sanofi excluding Opella Paris, France…
New Phase IIIB data shows Novartis Fabhalta improved hemoglobin levels in adult patients with paroxysmal nocturnal hemoglobinuria who switched from anti-C5 therapy
In the Phase IIIB APPULSE-PNH study, oral Fabhalta® (iptacopan) improved the average…
Press Release: Sequana Medical announces decision of major shareholders to invest in Second Tranche of Convertible Bridge Loan
SEQUANA MEDICAL ANNOUNCES DECISION OF MAJOR SHAREHOLDERS TO INVEST IN SECOND TRANCHE…
MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND
December 05, 2024 18:00 ET | Source: MediciNova, Inc. LA JOLLA, Calif.,…
Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan
December 05, 2024 18:00 ET | Source: Teva Pharmaceutical Industries Ltd Teva…
